Evan is an Investment principal at Philips Ventures based in Amsterdam, and currently serves as a Director of Carevive and Siilo. He’s also a member of the investment council for imec.xpand’s hardware-based nanotechnology fund.
Prior to joining Philips Ventures, Evan was the Chief Business Officer of RareCyte, a venture-backed life science company based in Seattle, Washington. Evan holds an MBA from the University of Oxford — where he was an OUI-SBS Fellow and graduated with distinction — and a bachelor’s degree from Gonzaga University.
By clicking on the link, you will be leaving the official Royal Philips Healthcare ("Philips") website. Any links to third-party websites that may appear on this site are provided only for your convenience and in no way represent any affiliation or endorsement of the information provided on those linked websites. Philips makes no representations or warranties of any kind with regard to any third-party websites or the information contained therein.